Skip to content

FDMT - 4D Molecular Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchF

4D Molecular Therapeutics Inc

FDMT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

F

FDMT4D Molecular Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $16.91
52-wk low: $5.97
Prev close: $11.31
Mkt cap: $925.9M
Beta: 2.69
P/S: 10.1x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$153.6M

P7
Point72
Steven Cohen · Q4 2025 13F
$11.5M
position
CI
Citadel
Ken Griffin · Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -194.7%
Market cap: $926M

Valuation

P/S10.06
P/B2.00

Quality

Operating margin-2037.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: FDMT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $925.89M
Beta: 2.69

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.0x

Profit margin

-194.7%

Op margin

-2037.0%

ROE

-43.2%

$9.1M

position

JS

Jim Simons

Q2 2026 13F

$8.2M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for FDMT

No recent Congress trade
No recent market-voice mention

Earnings per share

-$1.04+0.0%

-$1.04 expected

Next report

What the street expects next

EPS expected

-$1.04

-$1.09 to -$0.99

Revenue expected

$3.6M

7 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

0.03

Change in 30 days

-43.2%

ROA-25.1%

Growth

Beta2.69